Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Garland J. Scott Create: Alert

All | News | Filings
Date FiledTypeDescription
11/29/2022 4 Garland J. Scott (Director) has filed a Form 4 on ALX ONCOLOGY HOLDINGS INC
Txns: Granted 24,009 options to buy @ $10.07, valued at $241.8k
11/29/2022 3 Garland J. Scott (Director) has filed a Form 3 on ALX ONCOLOGY HOLDINGS INC
06/23/2022 4 Garland J. Scott (Director) has filed a Form 4 on Day One Biopharmaceuticals, Inc.
Txns: Granted 28,700 options to buy @ $16.29, valued at $467.5k
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/18/2021 4 Garland J. Scott (Director) has filed a Form 4 on Day One Biopharmaceuticals, Inc.
Txns: Granted 48,072 options to buy @ $24.65, valued at $1.2M
08/18/2021 3 Garland J. Scott (Director) has filed a Form 3 on Day One Biopharmaceuticals, Inc.
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/14/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
07/02/2020 4 Garland J. Scott (President and CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Disposed/sold 24,529 shares @ $18, valued at $441.5k
Granted 1,173 shares @ $8.36, valued at $9.8k
Disposed/sold 1,173 shares @ $18, valued at $21.1k
Disposed/sold 100,000 rights @ $0
Disposed/sold 50,000 rights @ $0
Disposed/sold 200,000 options to buy @ $12.79, valued at $2.6M
Disposed/sold 100,000 options to buy @ $12.79, valued at $1.3M
Disposed/sold 370,400 options to buy @ $0
Disposed/sold 153,399 restricted stock units @ $0
02/26/2020 4 Garland J. Scott (President and CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 150,000 rights @ $0
02/04/2020 4 Garland J. Scott (President and CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 50,000 shares @ $0
Paid exercise price by delivering 5,623 shares @ $12.89, valued at $72.5k
Granted 200,000 options to buy @ $12.79, valued at $2.6M
11/04/2019 4 Garland J. Scott (President and CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 21,549 shares @ $29.84, valued at $643k
06/07/2019 4 Garland J. Scott (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Granted 25,000 options to buy @ $5.43, valued at $135.8k
02/04/2019 4 Garland J. Scott (President and CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 30,100 shares @ $0
Granted 120,400 options to buy @ $27.1, valued at $3.3M
10/31/2018 4 Garland J. Scott (President and CEO) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 125,000 shares @ $0
Granted 250,000 options to buy @ $19.69, valued at $4.9M
10/17/2018 3 Garland J. Scott (President and CEO) has filed a Form 3 on PORTOLA PHARMACEUTICALS INC
06/20/2018 4 Garland J. Scott (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Granted 17,000 options to buy @ $18.8, valued at $319.6k
06/16/2017 4 Garland J. Scott (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Granted 17,000 options to buy @ $9.18, valued at $156.1k
09/02/2016 4 Garland J. Scott (SVP & Chief Commercial Officer) has filed a Form 4 on Relypsa Inc
Txns: Granted 4,167 shares @ $0
Unknown transaction of 2,470 shares @ $32, valued at $79k
Disposed/sold 16,042 shares @ $32, valued at $513.3k
Granted 16,667 options to buy @ $18.87, valued at $314.5k
Disposed/sold 25,000 options to buy @ $18.87, valued at $471.8k
Disposed/sold 100,000 options to buy @ $21.36, valued at $2.1M
Disposed/sold 35,000 options to buy @ $28.38, valued at $993.3k
08/17/2016 4 Garland J. Scott (SVP & Chief Commercial Officer) has filed a Form 4 on Relypsa Inc
Txns: Paid exercise price by delivering 705 shares @ $31.89, valued at $22.5k
06/17/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/07/2016 4 Garland J. Scott (SVP & Chief Commercial Officer) has filed a Form 4 on Relypsa Inc
Txns: Granted 2,083 shares @ $0
Paid exercise price by delivering 783 shares @ $19.96, valued at $15.6k
Granted 8,333 options to buy @ $18.87, valued at $157.2k
11/10/2015 4 Garland J. Scott (SVP & Chief Commercial Officer) has filed a Form 4 on Relypsa Inc
Txns: Granted 6,250 shares @ $0
08/12/2015 4 Garland J. Scott (SVP & Chief Commercial Officer) has filed a Form 4 on Relypsa Inc
Txns: Granted 7,500 shares @ $0
Granted 35,000 options to buy @ $28.38, valued at $993.3k
05/26/2015 4 Garland J. Scott (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Granted 10,000 options to buy @ $26.15, valued at $261.5k
11/18/2014 4 Garland J. Scott (SVP & Chief Commercial Officer) has filed a Form 4 on Relypsa Inc
Txns: Granted 100,000 options to buy @ $21.36, valued at $2.1M
11/12/2014 4 Garland J. Scott (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.
Txns: Granted 20,000 options to buy @ $43.3, valued at $866k
09/19/2013 4 Garland J. Scott (EVP & Chief Commerical Officer) has filed a Form 4 on EXELIXIS, INC.
Txns: Granted 150,000 options to buy @ $5.51, valued at $826.5k
09/21/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
10/24/2011 4 Garland J. Scott (EVP & Chief Commerical Officer) has filed a Form 4 on EXELIXIS INC
Txns: Granted 200,000 options to buy @ $5.47, valued at $1.1M
10/24/2011 3 Garland J. Scott (EVP & Chief Commerical Officer) has filed a Form 3 on EXELIXIS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy